![]() |
Volumn 13, Issue 5, 2007, Pages 296-297
|
Are anti-TNFα therapies too good? An audit of patients' compliance
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
ANTIBIOTIC AGENT;
ANTIRHEUMATIC AGENT;
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
ETANERCEPT;
INFLIXIMAB;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA ANTAGONIST;
UNCLASSIFIED DRUG;
IMMUNOLOGIC FACTOR;
ADULT;
AGED;
ANKYLOSING SPONDYLITIS;
ARTICLE;
CELLULITIS;
CHEST INFECTION;
COUGHING;
DRUG EFFECT;
DRUG EFFICACY;
DRUG WITHDRAWAL;
FEMALE;
FLU LIKE SYNDROME;
GENITAL TRACT INFECTION;
HERPES ZOSTER;
HUMAN;
INFECTION;
MAJOR CLINICAL STUDY;
MALE;
PATIENT ATTITUDE;
PATIENT COMPLIANCE;
PATIENT EDUCATION;
PATIENT SATISFACTION;
PHARYNGITIS;
PRIORITY JOURNAL;
RECTUM ABSCESS;
RECTUM DISEASE;
RHEUMATOID ARTHRITIS;
SKIN INFECTION;
TOOTH ABSCESS;
URINARY TRACT INFECTION;
COHORT ANALYSIS;
DRUG ANTAGONISM;
HEALTH SURVEY;
MEDICAL AUDIT;
SELF MEDICATION;
STATISTICS;
ADULT;
AGED;
AGED, 80 AND OVER;
ARTHRITIS, RHEUMATOID;
COHORT STUDIES;
FEMALE;
HEALTH SURVEYS;
HUMANS;
IMMUNOLOGIC FACTORS;
INFECTION;
MALE;
MEDICAL AUDIT;
PATIENT COMPLIANCE;
SELF MEDICATION;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 35148874201
PISSN: 10761608
EISSN: None
Source Type: Journal
DOI: 10.1097/RHU.0b013e3181581b51 Document Type: Article |
Times cited : (2)
|
References (4)
|